All the latest news on the marijuana space delivered directly to your inbox.
TheSeedInvestor
Read our Investor Dashboard on OTC:ABCCF TSX.v ABCN
There will be a sudden wave of "Marijuana Millionaires" in 2017 - will you be one?

 
13x13x1 READ MORE
Read the Investors Guide To Newly Emerging Marijuana Markets 
LEARN MORE
600x300
ABcann Global Adds Big Alcohol, Big Tobacco and Big Pharma Experience to the Team

Mr. Rick Fitzgerald brings extensive strategic marketing and senior leadership in the alcoholic beverage and tobacco industries to the Board of Directors. Dr. Michael Bumby brings extensive financial, international and capital markets experience to the executive team as Chief Financial Officer

13x13x1 READ MORE
600x300
Aurora Cannabis Submits Takeover Proposal to CanniMed Therapeutics Board

Aurora Cannabis Executes Lock-up Agreements with 38% of CanniMed Shareholders

13x13x1 READ MORE
600x300
CanniMed Acknowledges Aurora Press Release and Announces Exclusivity Agreement and Intention to Acquire Newstrike Resources Ltd.

Shareholders advised to take no action at this time. Details regarding acquisition transaction to be forthcoming.

13x13x1 READ MORE
600x300
Aurora Accelerates Warrant Expiry Date for Anticipated Proceeds of $50.8 Million

Aurora Cannabis elects to exercise its right under the warrant indenture governing the common share purchase warrants of the Company issued on February 28, 2017

13x13x1 READ MORE
600x300
Weed is the new craft beer, says former Budweiser exec: 'Ignore it at your peril' - From Financial Post

Chris Burggraeve is one of many entrepreneurs and investors increasingly flocking to the cannabis industry from the traditional business world

13x13x1 READ MORE
Please see full disclaimers on the TheSeedInvestor.com website applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimerDisclaimer.

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 
 
32x32x1   32x32x2  
TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260
info@theseedinvestor.com
 
©2019, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.